Viral Quasispecies: Dynamics, Interactions, and Pathogenesis*

Origin and Evolution of Viruses, Second Edition

Volumn , Issue , 2008, Pages 87-118

  Domingo, Esteban ^a,b   Escarmís, Cristina ^a   Menéndez Arias, Luis ^a   Perales, Celia ^a,b   Herrera, Mónica ^a   Novella, Isabel S ^c   Holland, John J ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47649124088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374153-0.00004-7     Document Type: Chapter

References (250)

1. J. Aaskov, K. Buzacott, H.M. Thu, K. Lowry and E.C. Holmes (2006) Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311 236-238.
2. A. Airaksinen, N. Pariente, L. Menendez-Arias and E. Domingo (2003) Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311 339-349.
3. A. Ali, H. Li, W.L. Schneider, D.J. Sherman, S. Gray, D. Smith and M.J. Roossinck (2006) Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus. J. Virol. 80 8345-8350.
4. J.P. Anderson, R. Daifuku and L.A. Loeb (2004) Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58 183-205.
5. R.H. Archer, C. Dykes, P. Gerondelis, A. Lloyd, P. Fay, R.C. Reichman, R.A. Bambara and L.M. Demeter (2000) Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture. J. Virol. 74 8390-8401.
6. A. Arias, C.M. Ruiz-Jarabo, C. Escarmis and E. Domingo (2004) Fitness increase of memory genomes in a viral quasispecies. J. Mol. Biol. 339 405-412.
7. A. Arias, R. Agudo, C. Ferrer-Orta, R. Perez-Luque, A. Airaksinen, E. Brocchi, et al. (2005) Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J. Mol. Biol. 353 1021-1032.
8. K.K. Arien, R.M. Troyer, Y. Gali, R.L. Colebunders, E.J. Arts and G. Vanham (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19 1555-1564.
9. J.J. Arnold, M. Vignuzzi, J.K. Stone, R. Andino and C.E. Cameron (2005) Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J. Biol. Chem. 280 25706-25716.
10. P. Auewarakul, O. Suptawiwat, A. Kongchanagul, C. Sangma, Y. Suzuki, K. Ungchusak, et al. (2007) An avian influenza H5N1 virus that binds to a human-type receptor. J. Virol. 81 9950-9955.
11. P. Baccam, R.J. Thompson, O. Fedrigo, S. Carpenter and J.L. Cornette (2001) PAQ: partition analysis of quasispecies. Bioinformatics 17 16-22.
12. N.K. Back, M. Nijhuis, W. Keulen, C.A. Boucher, B.O. Oude Essink, A.B. van Kuilenburg, et al. (1996) Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15 4040-4049.
13. E. Batschelet, E. Domingo and C. Weissmann (1976) The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1 27-32.
14. K. Bebenek and T.A. Kunkel (1993) The fidelity of retroviral reverse transcriptases. A.M. Skalka, S.P. Goff (Eds) Reverse Transcriptase New York: Cold Spring Harbor Laboratory Press 85-102.
15. C.K. Biebricher and E. Domingo (2007) The advantage of the high genetic diversity in RNA viruses. Future Virol. 2 35-38.
16. C.K. Biebricher and M. Eigen (2005) The error threshold. Virus Res. 107 117-127.
17. D. Botstein (1980) A theory of modular evolution for bacteriophages. Ann. NY Acad. Sci. 354 484-491.
18. C. Briones, A. Mas, G. Gomez-Mariano, C. Altisent, L. Menendez-Arias, V. Soriano and E. Domingo (2000) Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy. Virus Res. 66 13-26.
19. C. Briones, E. Domingo and C. Molina-París (2003) Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J. Mol. Biol. 331 213-229.
20. C. Briones, A. de Vicente, C. Molina-Paris and E. Domingo (2006) Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo. Gene 384 129-138.
21. F. Bushman (2002) Lateral DNA Transfer. Mechanisms and Consequences. New York: Cold Spring Harbor Laboratory Press
22. D.S. Callaway and A.S. Perelson (2002) HIV-1 infection and low steady state viral loads. Bull. Math. Biol. 64 29-64.
23. C. Carrillo, M. Borca, D.M. Moore, D.O. Morgan and F. Sobrino (1998) In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J. Gen. Virol. 79 1699-1706.
24. C.E. Cases-Gonzalez, S. Franco, M.A. Martinez and L. Menendez-Arias (2007) Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine. J. Mol. Biol. 365 298-309.
25. A.T. Ciota, A.O. Lovelace, K.A. Ngo, A.N. Le, J.G. Maffei, M.A. Franke, et al. (2007) Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture. Virology 357 165-174.
26. S.A. Clark, C. Calef and J.W. Mellors (2005) Mutations in retroviral genes associated with drug resistance. T. Leitner, B. Foley, B. Hahn, P. Marx, F. McCutchan, J. Mellors, S. Wolinsky, B. Korber (Eds) HIV Sequence Compendium 2005 Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory 80-174.
27. D.K. Clarke, E.A. Duarte, A. Moya, S.F. Elena, E. Domingo and J. Holland (1993) Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses. J. Virol. 67 222-228.
28. D.K. Clarke, E.A. Duarte, S.F. Elena, A. Moya, E. Domingo and J. Holland (1994) The red queen reigns in the kingdom of RNA viruses. Proc. Natl Acad. Sci. USA 91 4821-4824.
29. J.E. Clements, S.L. Gdovin, R.C. Montelaro and O. Narayan (1988) Antigenic variation in lentiviral diseases. Annu. Rev. Immunol. 6 139-159.
30. B. Clotet, L. Menéndez-Arias, J.M. Schapiro, D. Kuritzkes, D. Burger, A. Telenti, et al. (Eds) (2006) Guide to Management of HIV Drug Resistance, antiretrovirals pharmacokinetics and viral hepatitis in HIV infected subjects 7th edn. Barcelona, Spain: Fundació de Lluita contra la SIDA
31. R. Colonno, R. Rose, C. McLaren, A. Thiry, N. Parkin and J. Friborg (2004) Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. J. Infect. Dis. 189 1802-1810.
32. J.A. Collins, M.G. Thompson, E. Paintsil, M. Ricketts, J. Gedzior and L. Alexander (2004) Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants. J. Virol. 78 603-611.
33. J.H. Condra, W.A. Schleif, O.M. Blahy, L.J. Gabryelski, D.J. Graham, J.C. Quintero, et al. (1995) In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374 569-571.
34. S. Crotty, C.E. Cameron and R. Andino (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl Acad. Sci. USA 98 6895-6900.
35. S. Crowder and K. Kirkegaard (2005) Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 37 701-709.
36. L. Chao (1990) Fitness of RNA virus decreased by Muller's ratchet. Nature 348 454-455.
37. N. Charpentier, M. Davila, E. Domingo and C. Escarmis (1996) Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223 10-18.
38. I.S.Y. Chen, H. Koprowski, A. Srinivasan and P.K. Vogt (Eds) (1995) Transacting Functions of Human Retroviruses Berlin: Springer
39. K.M. Chumakov, L.B. Powers, K.E. Noonan, I.B. Roninson and I.S. Levenbook (1991) Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl Acad. Sci. USA 88 199-203.
40. H. Dahari, R.M. Ribeiro and A.S. Perelson (2007) Triphasic decline of hepatitis C virus RNA during antiviral therapy. Hepatology 46 16-21.
41. J.J. Davis (1997) Origins, acquisition and dissemination of antibiotic resistance determinants. D.J. Chadweick, J. Goode (Eds) Antibiotic Resitance: Origins, Evolution, Selection and Spread New York: John Wiley 15-35.
42. F. de la Iglesia and S.F. Elena (2007) Fitness declines in tobacco etch virus upon serial bottleneck transfers. J. Virol. 81 4941-4947.
43. J.C. de la Torre and J.J. Holland (1990) RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64 6278-6281.
44. J. Deval, K.L. White, M.D. Miller, N.T. Parkin, J. Courcambeck, P. Halfon, et al. (2004) Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations. J. Biol. Chem. 279 509-516.
45. N.M. Dixit, J.E. Layden-Almer, T.J. Layden and A.S. Perelson (2004) Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432 922-924.
46. E. Domingo (2000) Viruses at the edge of adaptation. Virology 270 251-253.
47. Domingo, E., ed. (2005[AU12]) Virus entry into error catastrophe as a new antiviral strategy. Virus Res. 107, 115–228.
48. Domingo, E., ed. (2006) Quasispecies: concepts and implications for virology. Curr. Top. Microbiol. Immunol. 299.
49. E. Domingo (2007) Virus evolution. D.M. Knipe, P.M. Howley, et al., (Eds) Fields Virology 5th ed. Philadelphia: Lippincott Williams & Wilkins 389-421.
50. E. Domingo and J. Gomez (2007) Quasispecies and its impact on viral hepatitis. Virus Res. 127 131-150.
51. E. Domingo and J.J. Holland (1997) RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51 151-178.
52. E. Domingo, R.A. Flavell and C. Weissmann (1976) In vitro site-directed mutagenesis: generation and properties of an infectious extracistronic mutant of bacteriophage Qb. Gene 1 3-25.
53. E. Domingo, D. Sabo, T. Taniguchi and C. Weissmann (1978) Nucleotide sequence heterogeneity of an RNA phage population. Cell 13 735-744.
54. P. Dorr, M. Westby, S. Dobbs, P. Griffin, B. Irvine, M. Macartney, et al. (2005) Maraviroc (UK-427, 857), a potent, orally bioavailable and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 49 4721-4732.
55. L. Doyon, G. Croteau, D. Thibeault, F. Poulin, L. Pilote and D. Lamarre (1996) Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70 3763-3769.
56. L. Doyon, C. Payant, L. Brakier-Gingras and D. Lamarre (1998) Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors. J. Virol. 72 6146-6150.
57. J.W. Drake (1993) Rates of spontaneous mutation among RNA viruses. Proc. Natl Acad. Sci. USA 90 4171-4175.
58. J.W. Drake and J.J. Holland (1999) Mutation rates among RNA viruses. Proc. Natl Acad. Sci. USA 96 13910-13913.
59. J.W. Drake, B. Charlesworth, D. Charlesworth and J.F. Crow (1998) Rates of spontaneous mutation. Genetics 148 1667-1686.
60. E. Duarte, D. Clarke, A. Moya, E. Domingo and J. Holland (1992) Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc. Natl Acad. Sci. USA 89 6015-6019.
61. E.A. Duarte, I.S. Novella, S. Ledesma, D.K. Clarke, A. Moya, S.F. Elena, et al. (1994) Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68 4295-4301.
62. E.A. Duarte, I.S. Novella, S.C. Weaver, E. Domingo, S. Wain-Hobson, D.K. Clarke, et al. (1994) RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3 201-214.
63. C. Dykes, K. Fox, A. Lloyd, M. Chiulli, E. Morse and L.M. Demeter (2001) Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants. Virology 285 193-203.
64. P.S. Eastman, J. Mittler, R. Kelso, C. Gee, E. Boyer, J. Kolberg, et al. (1998) Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy. J. Virol. 72 5154-5164.
65. M. Eigen (1971) Self-organization of matter and the evolution of biological macromolecules. Naturwissenschaften 58 465-523.
66. M. Eigen (1992) Steps towards Life. Oxford: Oxford University Press
67. M. Eigen (2000) Natural selection: a phase transition? Biophys. Chem. 85 101-123.
68. M. Eigen (2002) Error catastrophe and antiviral strategy. Proc. Natl Acad. Sci. USA 99 13374-13376.
69. M. Eigen and C.K. Biebricher (1988) Sequence space and quasispecies distribution. E. Domingo, P. Ahlquist, J.J. Holland (Eds) RNA Genetics Vol. 3 Boca Raton, FL: CRC Press 211-245.
70. M. Eigen and P. Schuster (1979) The Hypercycle. A Principle of Natural Self-organization. Berlin: Springer
71. C. Escarmís, M. Dávila, N. Charpentier, A. Bracho, A. Moya and E. Domingo (1996) Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264 255-267.
72. C. Escarmís, M. Dávila and E. Domingo (1999) Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285 495-505.
73. C. Escarmís, G. Gómez-Mariano, M. Dávila, E. Lázaro and E. Domingo (2002) Resistance to extinction of low fitness virus subjected to plaque-to- plaque transfers: diversification by mutation clustering. J. Mol. Biol. 315 647-661.
74. C. Escarmís, E. Lázaro and S.C. Manrubia (2006) Population bottlenecks in quasispecies dynamics. Curr. Top. Microbiol. Immunol. 299 141-170.
75. P. Farci, A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J.C. Melpolder, et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 339-344.
76. G. Fernandez, B. Clotet and M.A. Martinez (2007) Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J. Virol. 81 2485-2496.
77. C. Ferrer-Orta, A. Arias, R. Perez-Luque, C. Escarmis, E. Domingo and N. Verdaguer (2004) Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J. Biol. Chem. 279 47212-47221.
78. C. Ferrer-Orta, A. Arias, C. Escarmis and N. Verdaguer (2006) A comparison of viral RNA-dependent RNA polymerases. Curr. Opin. Struct. Biol. 16 27-34.
79. C. Ferrer-Orta, A. Arias, R. Perez-Luque, C. Escarmis, E. Domingo and N. Verdaguer (2007) Sequential structures provide insights into the fidelity of RNA replication. Proc. Natl Acad. Sci. USA 104 9463-9468.
80. D.B. Finkelstein, S. Mukatira, P.K. Mehta, J.C. Obenauer, X. Su, R.G. Webster and C.W. Naeve (2007) Persistent host markers in pandemic and H5N1 influenza viruses. J. Virol. 81 10292-10299.
81. F.A. Frankel, C.F. Invernizzi, M. Oliveira and M.A. Wainberg (2007) Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations. Aids 21 665-675.
82. E.C. Friedberg, G.C. Walker, W. Siede, R.D. Wood, R.A. Schultz and T. Ellenberger (2006) DNA Repair and Mutagenesis. Washington, DC: American Society for Microbiology
83. S.D. Frost, M.J. Dumaurier, S. Wain-Hobson and A.J. Brown (2001) Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc. Natl Acad. Sci. USA 98 6975-6980.
84. J.E. Galagan and E.U. Selker (2004) RIP: the evolutionary cost of genome defense. Trends Genet. 20 417-423.
85. J.G. Garcia-Lerma, S. Nidtha, K. Blumoff, H. Weinstock and W. Heneine (2001) Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc. Natl Acad. Sci. USA 98 13907-13912.
86. J. García-Arriaza, S.C. Manrubia, M. Toja, E. Domingo and C. Escarmís (2004) Evolutionary transition toward defective RNAs that are infectious by complementation. J. Virol. 78 11678-11685.
87. J. García-Arriaza, E. Domingo and C. Escarmís (2005) A segmented form of foot-and-mouth disease virus interferes with standard virus: a link between interference and competitive fitness. Virology 335 155-164.
88. J. García-Arriaza, S. Ojosnegros, M. Dávila, E. Domingo and C. Escarmis (2006) Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes. J. Mol. Biol. 360 558-572.
89. J. Garcia-Arriaza, E. Domingo and C. Briones (2007) Characterization of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications. Virus Res. 129 123-134.
90. J.G. Garcia-Lerma, H. MacInnes, D. Bennett, H. Weinstock and W. Heneine (2004) Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine. J. Virol. 78 7545-7552.
91. H. Gatanaga, Y. Suzuki, H. Tsang, K. Yoshimura, M.F. Kavlick, K. Nagashima, et al. (2002) Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors. J. Biol. Chem. 277 5952-5961.
92. G.F. Gause (1971) The Struggle for Existence. New York: Dover
93. L. Ge, J. Zhang, X. Zhou and H. Li (2007) Genetic structure and population variability of tomato yellow leaf curl china virus. J. Virol. 81 5902-5907.
94. P. Gerondelis, R.H. Archer, C. Palaniappan, R.C. Reichman, P.J. Fay, R.A. Bambara and L.M. Demeter (1999) The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- and DNA 3′-end-directed RNase H activities. J. Virol. 73 5803-5813.
95. C. González-López, A. Arias, N. Pariente, G. Gómez-Mariano and E. Domingo (2004) Preextinction viral RNA can interfere with infectivity. J. Virol. 78 3319-3324.
96. C. González-López, G. Gómez-Mariano, C. Escarmís and E. Domingo (2005) Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect. Genet. Evol. 5 366-374.
97. M.F. Goodman and K.D. Fygenson (1998) DNA polymerase fidelity: from genetics toward a biochemical understanding. Genetics 148 1475-1482.
98. A.E. Gorbalenya (1995) Origin of RNA viral genomes; approaching the problem by comparative sequence analysis. A. Gibbs, C.H. Calisher, F. Garcia-Arenal (Eds) Molecular Basis of Virus Evolution Cambridge: Cambridge University Press 49-66.
99. J. Goudsmit, A. de Ronde, E. de Rooij and R. de Boer (1997) Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J. Virol. 71 4479-4484.
100. A. Grande-Pérez, S. Sierra, M.G. Castro, E. Domingo and P.R. Lowenstein (2002) Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl Acad. Sci. USA 99 12938-12943.
101. A. Grande-Pérez, G. Gómez-Mariano, P.R. Lowenstein and E. Domingo (2005) Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J. Virol. 79 10451-10459.
102. A. Grande-Pérez, E. Lazaro, P. Lowenstein, E. Domingo and S.C. Manrubia (2005) Suppression of viral infectivity through lethal defection. Proc. Natl Acad. Sci. USA 102 4448-4452.
103. I.P. Greene, E. Wang, E.R. Deardorff, R. Milleron, E. Domingo and S.C. Weaver (2005) Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J. Virol. 79 14253-14260.
104. D. Grimm, P. Staeheli, M. Hufbauer, I. Koerner, L. Martinez-Sobrido, A. Solorzano, et al. (2007) Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc. Natl Acad. Sci. USA 104 6806-6811.
105. P.R. Harrigan, S. Bloor and B.A. Larder (1998) Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72 3773-3778.
106. K.S. Harris, W. Brabant, S. Styrchak, A. Gall and R. Daifuku (2005) KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral Res. 67 1-9.
107. M. Herrera, J. Garcia-Arriaza, N. Pariente, C. Escarmis and E. Domingo (2007) Molecular basis for a lack of correlation between viral fitness and cell killing capacity. PLoS Pathog. 3 e53.
108. D.A. Hickey and M.R. Rose (1988) The role of gene transfer in the evolution of eukaryotic sex. R.E. Michod, B.R. Levin (Eds) The Evolution of Sex Sunderland, MA: Sinauer 161-175.
109. J. Holland and E. Domingo (1998) Origin and evolution of viruses. Virus Genes 16 13-21.
110. J.J. Holland, K. Spindler, F. Horodyski, E. Grabau, S. Nichol and S. VandePol (1982) Rapid evolution of RNA genomes. Science 215 1577-1585.
111. J.J. Holland, E. Domingo, J.C. de la Torre and D.A. Steinhauer (1990) Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64 3960-3962.
112. J.J. Holland, J.C. de la Torre, D.K. Clarke and E. Duarte (1991) Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65 2960-2967.
113. Z. Hu, F. Giguel, H. Hatano, P. Reid, J. Lu and D.R. Kuritzkes (2006) Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1. J. Virol. 80 7020-7027.
114. W. Huang, A. Gamarnik, K. Limoli, C.J. Petropoulos and J.M. Whitcomb (2003) Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. J. Virol. 77 1512-1523.
115. Y. Huang, S.L. Rosenkranz and H. Wu (2003) Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity. Math. Biosci. 184 165-186.
116. M.A. Huynen, P.F. Stadler and W. Fontana (1996) Smoothness within ruggedness: the role of neutrality in adaptation. Proc. Natl Acad. Sci. USA 93 397-401.
117. M.D. Iglesias-Ussel, C. Casado, E. Yuste, I. Olivares and C. Lopez-Galindez (2002) In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants. J. Gen. Virol. 83 93-101.
118. A. Ishihama, K. Mizumoto, K. Kawakami, A. Kato and A. Honda (1986) Proofreading function associated with the RNA-dependent RNA polymerase from influenza virus. J. Biol. Chem. 261 10417-10421.
119. A.K. Iversen, R.W. Shafer, K. Wehrly, M.A. Winters, J.I. Mullins, B. Chesebro and T.C. Merigan (1996) Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70 1086-1090.
120. R.E. Jeeninga, W. Keulen, C. Boucher, R.W. Sanders and B. Berkhout (2001) Evolution of AZT resistance in HIV-1: the 41–70 intermediate that is not observed in vivo has a replication defect. Virology 283 294-305.
121. V.A. Johnson, F. Brun-Vezinet, B. Clotet, D.R. Kuritzkes, D. Pillay, J.M. Schapiro and D.D. Richman (2006) Update of the drug resistance mutations in HIV-1: Fall 2006. Top. HIV Med. 14 125-130.
122. C. Jridi, J.F. Martin, V. Marie-Jeanne, G. Labonne and S. Blanc (2006) Distinct viral populations differentiate and evolve independently in a single perennial host plant. J. Virol. 80 2349-2357.
123. R. Kantor, W.J. Fessel, A.R. Zolopa, D. Israelski, N. Shulman, J.G. Montoya, et al. (2002) Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy. Antimicrob. Agents Chemother. 46 1086-1092.
124. A. Kaur, R.M. Grant, R.E. Means, H. McClure, M. Feinberg and R.P. Johnson (1998) Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72 9597-9611.
125. W. Keulen, N.K. Back, A. van Wijk, C.A. Boucher and B. Berkhout (1997) Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 71 3346-3350.
126. J.T. Kimata, L. Kuller, D.B. Anderson, P. Dailey and J. Overbaugh (1999) Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5 535-541.
127. L.A. Kohlstaedt, J. Wang, J.M. Friedman, P.A. Rice and T.A. Steitz (1992) Crystal structure at 3, 5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256 1783-1790.
128. D. Kolakofsky, L. Roux, D. Garcin and R.W. Ruigrok (2005) Paramyxovirus mRNA editing, the “rule of six” and error catastrophe: a hypothesis. J. Gen. Virol. 86 1869-1877.
129. E.V. Koonin, T.G. Senkevich and V.V. Dolja (2006) The ancient Virus World and evolution of cells. Biol. Direct 1 29.
130. P. Kosalaraksa, M.F. Kavlick, V. Maroun, R. Le and H. Mitsuya (1999) Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay. J. Virol. 73 5356-5363.
131. T.A. Kunkel (1990) Misalignment-mediated DNA synthesis errors. Biochemistry 29 8003-8011.
132. B.A. Larder (1994) Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. J. Gen. Virol. 75(Pt 5), 951-957.
133. B.A. Larder, G. Darby and D.D. Richman (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243 1731-1734.
134. E. Lazaro, C. Escarmis, J. Perez-Mercader, S.C. Manrubia and E. Domingo (2003) Resistance of virus to extinction on bottleneck passages: Study of a decaying and fluctuating pattern of fitness loss. Proc. Natl Acad. Sci. USA 100 10830-10835.
135. S.D. Lazarowitz (2007) Plant viruses. D.M. Dnipe, P.M. Howley (Eds) Fields Virology Philadelphia: Lippincot Williams and Wilkins 641-705.
136. C.H. Lee, D.L. Gilbertson, I.S. Novella, R. Huerta, E. Domingo and J.J. Holland (1997) Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J. Virol. 71 3636-3640.
137. C. Leroux, C.J. Issel and R.C. Montelaro (1997) Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71 9627-9639.
138. L.A. Loeb, J.M. Essigmann, F. Kazazi, J. Zhang, K.D. Rose and J.I. Mullins (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl Acad. Sci. USA 96 1492-1497.
139. J. Lu, P. Sista, F. Giguel, M. Greenberg and D.R. Kuritzkes (2004) Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20). J. Virol. 78 4628-4637.
140. V.V. Lukashov, R. Huismans, M.F. Jebbink, S.A. Danner, R.J. de Boer and J. Goudsmit (2001) Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs. AIDS Res. Hum. Retroviruses 17 807-818.
141. Y. Maeda, D.J. Venzon and H. Mitsuya (1998) Altered drug sensitivity, fitness and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance. J. Infect. Dis. 177 1207-1213.
142. S.C. Manrubia, C. Escarmis, E. Domingo and E. Lazaro (2005) High mutation rates, bottlenecks and robustness of RNA viral quasispecies. Gene 347 273-282.
143. S.C. Manrubia, J. Garcia-Arriaza, E. Domingo and C. Escarmís (2006) Long-range transport and universality classes in in vitro viral infection spread. Europhys. Lett. 74 547-553.
144. P.I. Marcus, L.L. Rodriguez and M.J. Sekellick (1998) Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J. Virol. 72 542-549.
145. J. Martinez-Picado, A.V. Savara, L. Sutton and R.T. D'Aquila (1999) Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73 3744-3752.
146. M.A. Martinez, C. Carrillo, F. Gonzalez-Candelas, A. Moya, E. Domingo and F. Sobrino (1991) Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J. Virol. 65 3954-3957.
147. A. Mas, M. Parera, C. Briones, V. Soriano, M.A. Martínez, E. Domingo and L. Menéndez-Arias (2000) Role of a dipeptide insertion between codons 69–70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J. 19 5752-5761.
148. T. Matamoros, S. Franco, B.M. Vazquez-Alvarez, A. Mas, M.A. Martinez and L. Menendez-Arias (2004) Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers. J. Biol. Chem. 279 24569-24577.
149. J. Maynard-Smith (1976) The Evolution of Sex. Cambridge: Cambridge University Press
150. J. Maynard Smith and E. Szathmary (1995) The Major Transitions in Evolution. Oxford: W.H. Freeman
151. L. Menendez-Arias (2002) Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol. Sci. 23 381-388.
152. L. Menendez-Arias, T. Matamoros and C.E. Cases-Gonzalez (2006) Insertions and deletions in HIV-1 reverse transcriptase: consequences for drug resistance and viral fitness. Curr. Pharm. Des. 12 1811-1825.
153. J.R. Mesters, J. Tan and R. Hilgenfeld (2006) Viral enzymes. Curr. Opin. Struct. Biol. 16 776-786.
154. M.D. Miller, P.D. Lamy, M.D. Fuller, A.S. Mulato, N.A. Margot, T. Cihlar and J.M. Cherrington (1998) Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivity. Mol. Pharmacol. 54 291-297.
155. E. Minskaia, T. Hertzig, A.E. Gorbalenya, V. Campanacci, C. Cambillau, B. Canard and J. Ziebuhr (2006) Discovery of an RNA virus 3′–>5′ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl Acad. Sci. USA 103 5108-5113.
156. H. Mitsuya, K.J. Weinhold, P.A. Furman, M.H. St Clair, S.N. Lehrman, R.C. Gallo, et al. (1985) 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl Acad. Sci. USA 82 7096-7100.
157. I.M. Moreno, J.M. Malpica, E. Rodriguez-Cerezo and F. Garcia-Arenal (1997) A mutation in tomato aspermy cucumovirus that abolishes cell-to-cell movement is maintained to high levels in the viral RNA population by complementation. J. Virol. 71 9157-9162.
158. J.A. Mudd, R.W. Leavitt, D.T. Kingsbury and J.J. Holland (1973) Natural selection of mutants of vesicular stomatitis virus by cultured cells of Drosophila melanogaster. J. Gen. Virol. 20 341-351.
159. V. Muller, B. Ledergerber, L. Perrin, T. Klimkait, H. Furrer, A. Telenti, et al. (2006) Stable virulence levels in the HIV epidemic of Switzerland over two decades. Aids 20 889-894.
160. L. Myint, M. Matsuda, Z. Matsuda, Y. Yokomaku, T. Chiba, A. Okano, et al. (2004) Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1. Antimicrob. Agents Chemother, 48 444-452.
161. P.D. Nagy, C.D. Carpenter and A.E. Simon (1997) A novel 3′-end repair mechanism in an RNA virus. Proc. Natl Acad. Sci. USA 94 1113-1118.
162. I. Nájera, A. Holguín, M.E. Quiñones-Mateu, M.A. Muñoz-Fernández, R. Nájera, C. López-Galíndez and E. Domingo (1995) Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69 23-31.
163. I.S. Novella and B.E. Ebendick-Corpus (2004) Molecular basis of fitness loss and fitness recovery in vesicular stomatitis virus. J. Mol. Biol. 342 1423-1430.
164. I.S. Novella, D.K. Clarke, J. Quer, E.A. Duarte, C.H. Lee, S.C. Weaver, et al. (1995) Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells. J. Virol. 69 6805-6809.
165. I.S. Novella, E.A. Duarte, S.F. Elena, A. Moya, E. Domingo and J.J. Holland (1995) Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl Acad. Sci. USA 92 5841-5844.
166. I.S. Novella, S.F. Elena, A. Moya, E. Domingo and J.J. Holland (1995) Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J. Virol. 69 2869-2872.
167. I.S. Novella, M. Cilnis, S.F. Elena, J. Kohn, A. Moya, E. Domingo and J.J. Holland (1996) Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance. J. Virol. 70 6414-6417.
168. I.S. Novella, C.L. Hershey, C. Escarmis, E. Domingo and J.J. Holland (1999) Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J. Mol. Biol. 287 459-465.
169. I.S. Novella, J. Quer, E. Domingo and J.J. Holland (1999) Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J. Virol. 73 1668-1671.
170. I.S. Novella, B.E. Ebendick-Corpus, S. Zarate and E.L. Miller (2007) Emergence of mammalian cell-adapted vesicular stomatitis virus from persistent infections of insect vector cells. J. Virol. 81 6664-6668.
171. M.A. Nowak (2006) Evolutionary Dynamics. Cambridge, MA and London: The Belknap Press of Harvard University Press
172. M.A. Nowak and R.M. May (2000) Virus dynamics. Mathematical Principles of Immunology and Virology. New York: Oxford University Press
173. M. Nowak and P. Schuster (1989) Error thresholds of replication in finite populations mutation frequencies and the onset of Muller's ratchet. J. Theor. Biol. 137 375-395.
174. J.I. Nuñez, N. Molina, E. Baranowski, E. Domingo, S. Clark, A. Burman, et al. (2007) Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host. J. Virol. 81 8497-8506.
175. L.E. Orgel (1963) The maintenance of the accuracy of protein synthesis and its relevance to ageing. Proc. Natl Acad. Sci. USA 49 517-521.
176. N. Pariente, S. Sierra, P.R. Lowenstein and E. Domingo (2001) Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol. 75 9723-9730.
177. N. Pariente, A. Airaksinen and E. Domingo (2003) Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol. 77 7131-7138.
178. C.R. Parrish and Y. Kawaoka (2005) The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu. Rev. Microbiol. 59 553-586.
179. V.K. Pathak and H.M. Temin (1992) 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66 3093-3100.
180. J.M. Pawlotsky, G. Germanidis, A.U. Neumann, M. Pellerin, P.O. Frainais and D. Dhumeaux (1998) Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J. Virol. 72 2795-2805.
181. J. Peleg (1971) Growth of viruses in arthropod cell cultures: applications. I. Attenuation of Semliki Forest (SF) virus in continuously cultured Aedes aegypti mosquito cells (Peleg) as a step in production of vaccines. Curr. Top. Microbiol. Immunol. 55 155-161.
182. H. Pelemans, A. Aertsen, K. Van Laethem, A.M. Vandamme, E. De Clercq, M.J. Perez-Perez, et al. (2001) Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138. Virology 280 97-106.
183. C. Perales, R. Mateo, M.G. Mateu and E. Domingo (2007) Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J. Mol. Biol. 369 985-1000.
184. A.S. Perelson and T.J. Layden (2007) Ribavirin: is it a mutagen for hepatitis C virus? Gastroenterology 132 2050-2052.
185. C.J. Peters (2007) Emerging Viral Diseases. 5th edn Philadelphia: Lippincott Williams and Wilkins pp. 605–625.
186. S.C. Pettit, G.J. Henderson, C.A. Schiffer and R. Swanstrom (2002) Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J. Virol. 76 10226-10233.
187. J.K. Pfeiffer and K. Kirkegaard (2003) A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl Acad. Sci. USA 100 7289-7294.
188. J.K. Pfeiffer and K. Kirkegaard (2005) Increased fidelity reduces poliovirus fitness under selective pressure in mice. PLoS Pathog. 1 102-110.
189. J.K. Pfeiffer and K. Kirkegaard (2006) Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc. Natl Acad. Sci. USA 103 5520-5525.
190. J.G. Prado, T. Wrin, J. Beauchaine, L. Ruiz, C.J. Petropoulos, S.D. Frost, et al. (2002) Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. Aids 16 1009-1017.
191. M.E. Quiñones-Mateu, A. Mas, T. Lain de Lera, V. Soriano, J. Alcami, M.M. Lederman and E. Domingo (1998) LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res. 57 11-20.
192. M.E. Quiñones-Mateu, M. Tadele, M. Parera, A. Mas, J. Weber, H.R. Rangel, et al. (2002) Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation. J. Virol. 76 10546-10552.
193. M.E. Quiñones-Mateu and E. Arts (2006) Virus fitness: concept, qunatification and application to HIV population dynamics. Curr. Top. Microbiol. Immunol. 299 83-140.
194. J.D. Reeves, S.A. Gallo, N. Ahmad, J.L. Miamidian, P.E. Harvey, M. Sharron, et al. (2002) Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density and fusion kinetics. Proc. Natl Acad. Sci. U S A 99 16249-16254.
195. J.D. Reeves, F.H. Lee, J.L. Miamidian, C.B. Jabara, M.M. Juntilla and R.W. Doms (2005) Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity and virus neutralization. J. Virol. 79 4991-4999.
196. D. Reznick and J. Travis (1996) The empirical study of adaptation in natural populations. M.R. Rose, G.V. Lander (Eds) Adaptation San Diego: Academic Press 243-289.
197. L.T. Rimsky, D.C. Shugars and T.J. Matthews (1998) Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72 986-993.
198. B.H. Robertson, R.W. Jansen, B. Khanna, A. Totsuka, O.V. Nainan, G. Siegl, et al. (1992) Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol. 73 1365-1377.
199. L. Roux, A.E. Simon and J.J. Holland (1991) Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 40 181-211.
200. C.M. Ruiz-Jarabo, A. Arias, E. Baranowski, C. Escarmís and E. Domingo (2000) Memory in viral quasispecies. J. Virol. 74 3543-3547.
201. C.M. Ruiz-Jarabo, A. Arias, C. Molina-París, C. Briones, E. Baranowski, C. Escarmís and E. Domingo (2002) Duration and fitness dependence of quasispecies memory. J. Mol. Biol. 315 285-296.
202. C.M. Ruiz-Jarabo, C. Ly, E. Domingo and J.C. de la Torre (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308 37-47.
203. C.M. Ruiz-Jarabo, E. Miller, G. Gómez-Mariano and E. Domingo (2003) Synchronous loss of quasispecies memory in parallel viral lineages: a deterministic feature of viral quasispecies. J. Mol. Biol. 333 553-563.
204. D.B. Saakian and C.K. Hu (2006) Exact solution of the Eigen model with general fitness functions and degradation rates. Proc. Natl Acad. Sci. USA, 103 4935-4939.
205. R. Sanjuan, J.M. Cuevas, V. Furio, E.C. Holmes and A. Moya (2007) Selection for robustness in mutagenized RNA viruses. PLoS Genet. 3 e93.
206. T.W. Scott, S.C. Weaver and V.L. Mallampali (1994) Evolution of mosquito-borne viruses. S.S. Morse (Eds) Evolutionary Biology of Viruses New York: Raven Press 293-324.
207. J.C. Schmit, J. Cogniaux, P. Hermans, C. Van Vaeck, S. Sprecher, B. Van Remoortel, et al. (1996) Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J. Infect. Dis. 174 962-968.
208. H.B. Schock, V.M. Garsky and L.C. Kuo (1996) Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity. J. Biol. Chem. 271 31957-31963.
209. N. Sevilla, C.M. Ruiz-Jarabo, G. Gómez-Mariano, E. Baranowski and E. Domingo (1998) An RNA virus can adapt to the multiplicity of infection. J. Gen. Virol, 79 2971-2980.
210. R.W. Shafer, M.A. Winters, S. Palmer and T.C. Merigan (1998) Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann. Intern. Med. 128 906-911.
211. P.L. Sharma and C.S. Crumpacker (1997) Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation. J. Virol. 71 8846-88451.
212. P.L. Sharma and C.S. Crumpacker (1999) Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val. J. Virol. 73 8448-8456.
213. T. Shirasaka, M.F. Kavlick, T. Ueno, W.Y. Gao, E. Kojima, M.L. Alcaide, et al. (1995) Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl Acad. Sci. USA, 92 2398-2402.
214. M. Sierra, A. Airaksinen, C. González-López, R. Agudo, A. Arias and E. Domingo (2007) Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J. Virol. 81 2012-2024.
215. S. Sierra, M. Dávila, P.R. Lowenstein and E. Domingo (2000) Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity. J. Virol. 74 8316-8323.
216. M.S. Smolinski, M.A. Hamburg and J. Lederberg (2003) Microbial Threats to Health. Emergence, Detection and Response Washington DC: The National Academies Press
217. F. Sobrino and T. Mettenleiter (2008) Animal Viruses: Molecular Biology. UK: Horizon Scientific Press
218. D.A. Steinhauer, E. Domingo and J.J. Holland (1992) Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 122 281-288.
219. Y. Suzuki (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28 399-408.
220. J. Swetina and P. Schuster (1982) Self-replication with errors. A model for polynucleotide replication. Biophys. Chem. 16 329-345.
221. N. Tapia, G. Fernandez, M. Parera, G. Gomez-Mariano, B. Clotet, M. Quiñones-Mateu, et al. (2005) Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection. Virology 338 1-8.
222. H.M. Temin (1989) Is HIV unique or merely different? J. AIDS 2 1-9.
223. H.M. Temin (1993) The high rate of retrovirus variation results in rapid evolution. S.S. Morse (Eds) Emerging Viruses Oxford: Oxford University Press 219-225.
224. M.N. Teng, M.B. Oldstone and J.C. de la Torre (1996) Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. Virology 223 113-119.
225. L. Van Valen (1973) A new evolutionary law. Evol. Theory 1 1-30.
226. M. Vignuzzi, J.K. Stone, J.J. Arnold, C.E. Cameron and R. Andino (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439 344-348.
227. L.P. Villarreal (2005) Viruses and the Evolution of Life. Washington DC: ASM Press
228. J. Wang, C. Dykes, R.A. Domaoal, C.E. Koval, R.A. Bambara and L.M. Demeter (2006) The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNA(Lys, 3) that correlate with reductions in replication efficiency. Virology 348 462-474.
229. S.C. Weaver (1998) Recurrent emergence of Venezuelan equine encephalomyelitis. W.M. Sheld, J. Hughes (Eds) Emerging Infections Vol. 1 Washington DC: ASM Press 27-42.
230. W.J. Weibull (1951) A statistical distribution function of wide applicability. Appl. Mech. 18 293-297.
231. M. Westby, C. Smith-Burchnell, J. Mori, M. Lewis, M. Mosley, M. Stockdale, et al. (2007) Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J. Virol. 81 2359-2371.
232. K.L. White, N.A. Margot, T. Wrin, C.J. Petropoulos, M.D. Miller and L.K. Naeger (2002) Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity. Antimicrob. Agents Chemother 46 3437-3446.
233. C.O. Wilke and I..S. Novella (2003) Phenotypic mixing and hiding may contribute to memory in viral quasispecies. BMC Microbiol. 3 11.
234. C.O. Wilke, C. Ronnewinkel and T. Martinetz (2001) Dynamic fitness landscapes in molecular evolution. Phys. Rep. 349 395-446.
235. C.O. Wilke, J.L. Wang, C. Ofria, R.E. Lenski and C. Adami (2001) Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature 412 331-333.
236. C.O. Wilke, D.D. Reissig and I..S. Novella (2004) Replication at periodically changing multiplicity of infection promotes stable coexistence of competing viral populations. Evolution Int. J. Org. Evolution, 58 900-905.
237. C.O. Wilke, R. Foster and I..S. Novella (2006) Quasispecies in time-dependent environments. Curr. Top. Microbiol. Immunol. 299 33-50.
238. G.C. Williams (1992) Natural Selection. Domains, Levels and Challenges. New York, Oxford: Oxford University Press
239. A. Wlodawer and J. Vondrasek (1998) Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 27 249-284.
240. P.F. Wright, G. Neumann, Y. Kawaoka (2007) Orthomyxoviruses. D.M. Dnipe, P.M. Howley, et al., (Eds) Fields Virology 5th edn Philadelphia: Lippincott Williams & Wilkins 1691-1740.
241. C.A. Wyatt, L. Andrus, B. Brotman, F. Huang, D.H. Lee and A.M. Prince (1998) Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J. Virol. 72 1725-1730.
242. K. Yamada, A. Mori, M. Seki, J. Kimura, S. Yuasa, Y. Matsuura and T. Miyamura (1998) Critical point mutations for hepatitis C virus NS3 proteinase. Virology 246 104-112.
243. Y. Yang, M.E. Halloran, J.D. Sugimoto and I.M. Longini (2007) Detecting human-to-human transmission of avian influenza A (H5N1). Emerging Infect. Dis. 13 1348-1353.
244. S. Yerly, A. Rakik, S.K. De Loes, B. Hirschel, D. Descamps, F. Brun-Vezinet and L. Perrin (1998) Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J. Virol. 72 3520-3523.
245. K. Yusa, W. Song, M. Bartelmann and S. Harada (2002) Construction of a human immunodeficiency virus type 1 (HIV-1) library containing random combinations of amino acid substitutions in the HIV-1 protease due to resistance by protease inhibitors. J. Virol. 76 3031-3037.
246. E. Yuste, S. Sánchez-Palomino, C. Casado, E. Domingo and C. López-Galíndez (1999) Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events. J. Virol. 73 2745-2751.
247. S. Zárate and I..S. Novella (2004) Vesicular stomatitis virus evolution during alternation between persistent infection in insect cells and acute infection in mammalian cells is dominated by the persistence phase. J. Virol. 78 12236-12242.
248. L. Zhang, Y. Huang, H. Yuan, B.K. Chen, J. Ip and D.D. Ho (1997) Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 71 5608-5613.
249. X. Zhang, M. Hasoksuz, D. Spiro, R. Halpin, S. Wang, A. Vlasova, et al. (2007) Quasispecies of bovine enteric and respiratory coronaviruses based on complete genome sequences and genetic changes after tissue culture adaptation. Virology 363 1-10.
250. D. Zimmern (1988) Evolution of RNA viruses. E. Domingo, J.J. Holland, P. Ahlquist (Eds) RNA Genetics Vol. 2 Florida: CRC Press Inc 211-240.